Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Arena Rises After CEO Sees `Path Forward' From Diet Pill's FDA Rejection
Bloomberg
Monday, October 25, 2010 - 8:13pm
tags:
Arena Pharmaceuticals, FDA, Jack Lief
Amarin's Potential Blockbuster in the Making
Seeking Alpha
Monday, October 25, 2010 - 5:50pm
tags:
Amarin, GSK, AMR101
Drugmakers top list of DOJ fraud settlements
Yahoo/AP
Monday, October 25, 2010 - 5:49pm
tags:
DOJ, fraud, Allergan
Amgen Beats Estimates With Shrinking Profit, Sales
Bloomberg
Monday, October 25, 2010 - 5:19pm
tags:
Amgen, earnings
Moms Ask FDA To Rescind Gardasil Approval
Pharmalot
Monday, October 25, 2010 - 5:17pm
tags:
Merck, FDA, vaccines, HPV, Gardasil
Timeline: A look back at Arena's lorcaserin
Fierce Biotech
Monday, October 25, 2010 - 12:35pm
tags:
obesity, Arena Pharmaceuticals
Abraxis deal done, Celgene eyes cancer franchise
Fierce Pharma
Monday, October 25, 2010 - 12:34pm
tags:
M&A, Celgene, companies
Savient Pharma: No Sale
TheStreet.com
Monday, October 25, 2010 - 12:31pm
tags:
M&A, Savient
Respectable Quarter for Dr Reddy's
Yahoo/Zacks.com
Monday, October 25, 2010 - 12:31pm
tags:
earnings, Dr Reddy's
The State of Oncology and the Future for Biotech Investors
Motley Fool
Monday, October 25, 2010 - 12:30pm
tags:
oncology, cancer, biotech, investors
Sinovac tumbles as drug indexes gain
Marketwatch
Monday, October 25, 2010 - 10:54am
tags:
drug stocks, Sinovac
GlaxoSmithKline - Upgrades & Downgrades
TheStreet.com
Monday, October 25, 2010 - 10:52am
tags:
GSK, analysts, downgrades, upgrades
Healthcare Fraud, Whistleblowers & US Treasury
Pharmalot
Monday, October 25, 2010 - 10:37am
tags:
whistleblowers, healthcare fraud, Allergan, AstraZeneca, Novartis, Forest Labs, Elan, Teva Pharmaceuticals, JNJ
3 Clear Winners of ESMO 2010
Seeking Alpha
Monday, October 25, 2010 - 10:35am
tags:
ESMO, cancer, Aveo Pharmaceutical, Arqule, Dendreon, Immunogen, Roche, Medarex, Seattle Genetics, Sanofi
Ariad Pharma cancer drug meets midstage study goal
Yahoo/AP
Monday, October 25, 2010 - 10:32am
tags:
Ariad Pharmaceuticals, clinical trials, cancer, ridaforolimus
Ahead of the Bell: Amgen to report 3Q after bell
Yahoo/AP
Monday, October 25, 2010 - 9:27am
tags:
Amgen, Prolia, earnings
How Bad Is the Non-Approval of Arena's Weight Loss Drug?
Seeking Alpha
Monday, October 25, 2010 - 9:05am
tags:
FDA, obsesity, Arena Pharmaceuticals
Novartis trial of meningococcal vaccine meets goal
Marketwatch
Monday, October 25, 2010 - 9:04am
tags:
Novartis, vaccines, Menveo, meningococcal disease
Alcon names Novartis' Vasella as chairman
Marketwatch
Monday, October 25, 2010 - 9:02am
tags:
Daniel Vasella, Novartis, Alcon, M&A
Is Abbott Laboratories a Sell?
Motley Fool
Monday, October 25, 2010 - 9:02am
tags:
Abbott Laboratories

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.